Senseonics Holdings (SENS) Current Deferred Revenue (2015 - 2018)

Senseonics Holdings (SENS) reported Current Deferred Revenue of $628000.0 for Q4 2018, up 6877.78% quarter-over-quarter from $9000.0 in Q1 2016.

Senseonics Holdings (SENS) Current Deferred Revenue (2015 - 2018) Analysis & Trends

Senseonics Holdings (SENS) has 3 years of Current Deferred Revenue data on file, last reported at $628000.0 in Q4 2018.

  • Current Deferred Revenue for Q4 2018 came in at $628000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was $628000.0 (changed N/A YoY), and the FY2018 annual result was $628000.0, changed N/A from the prior year.
  • Current Deferred Revenue advanced to $628000.0 in Q4 2018 per SENS's latest filing, from $9000.0 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $628000.0 in Q4 2018 and troughed at $7000.0 in Q4 2015.
  • A 3-year average of $214666.7 and a median of $9000.0 in 2016 frame the typical range for Current Deferred Revenue.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Senseonics Holdings 309.99 Mn 245.67 Mn 6.94 Mn

Historic Data

Download Data
DateValue
Dec 31, 2018 628,000.00
Mar 31, 2016 9,000.00
Dec 31, 2015 7,000.00